t.demir
TL2 Moderator · Kumasi
Contributes reviews on supplier material. Based in Kumasi.
Joined 13 March 2025 · last posted 2d
70Posts here
0Topics
0Solutions
1kLikes received
683Likes given
20Badges
198Days visited
3.2kPosts read
Recent activity
Full stream-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #73 · Practice › Interactions · 26 Jul 2026 · 23 likes post #72 is right about the mechanism and I think understates the practical bit. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #75 · Practice › Administration · 23 Jul 2026 · 21 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
Follow-up: Sleep quality changes during weight loss Replied, post #75 · Wellbeing › Sleep · 21 Jul 2026 · 33 likes Coming back to post #73, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Sleep quality changes during weight loss Replied, post #20 · Wellbeing › Sleep · 16 Jul 2026 · 17 likes Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs might increase even though appetite for food has decreased. Prioritising sleep is…
-
[2026 update] Waist circumference technique and its repeatability Replied, post #23 · Outcomes › Progress reports · 9 Jul 2026 · 30 likes post #22 is right about the mechanism and I think understates the practical bit. Measurement noise: day-to-day body mass varies by more than a kilogram on hydration,…
-
[2026 update] Documenting an adverse event properly Replied, post #3 · Safety › Adverse events · 7 Jul 2026 · 17 likes I read the opening post twice before replying, because I had assumed the opposite. Where to report: in many countries there is a pharmacovigilance system where adverse…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #40 · Access › Pricing · 6 Jul 2026 · 0 likes This follows post #37 rather than contradicting it. Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose,…
-
Coming back to: Telehealth prescribing models in the US Replied, post #7 · Regional › North America · 6 Jul 2026 · 27 likes Indigenous healthcare systems: different indigenous healthcare systems have different medication access. Pathways through tribal health systems differ from mainstream…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #65 · Start Here › Welcome · 6 Jul 2026 · 24 likes Picking up post #62: that is the part I would want checked first. The compound and evidence pages are updated regularly and they are worth reading when you are new.…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #57 · Analytics › Home & field testing · 6 Jul 2026 · 0 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #22 · Compounds › Retatrutide · 28 Jun 2026 · 26 likes On post #18 — agreed on the reasoning, with one qualification. How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an…
-
Injection volume, overload, and peak distortion Replied, post #6 · Analytics › HPLC & UHPLC · 13 May 2026 · 5 likes On post #2 — agreed on the reasoning, with one qualification. Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and…